SCHEMBL12358874

SCHEMBL12358874

NSc1ccccc1-c1ccc2[nH]c(CCc3ccc(F)cc3)nc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 2/20 0.45
▸ RAB9A P51151 6/20 0.43
▸ NPC1 O15118 4/20 0.43
▸ MAPT P10636 4/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ LMNA P02545 3/20 0.41
▸ HTT P42858 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ MAPK13 O15264 1/20 0.39
▸ GCGR P47871 1/20 0.39
▸ MAPK12 P53778 1/20 0.39
▸ MAPK11 Q15759 1/20 0.39
▸ MAPK14 Q16539 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ IDO1 P14902 1/20 0.38
▸ PDE10A Q9Y233 1/20 0.38
▸ NTRK1 P04629 1/20 0.38
▸ NTRK2 Q16620 1/20 0.38
▸ BRS3 P32247 1/20 0.37
▸ MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12359234 0.91 RAB9A (0.53) TRPV1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL12359134 0.85 TRPV1 (0.45) TRPV1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL12358671 0.83 TRPV1 (0.43) TRPV1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL12358835 0.81 RAB9A (0.44) TRPV1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL2241477 0.81 TRPV1 (0.68) TRPV1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL12359233 0.76 TRPV1 (0.57) TRPV1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL1794101 0.72 TRPV1 (0.60) TRPV1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL1798437 0.72 TRPV1 (0.62) TRPV1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL2241269 0.72 RAB9A (0.51) RAB9ANPC1MAPTSMN1; SMN2LMNA
Hydrochloric Acid SCHEMBL27141372 0.72 IDO1 (0.51) TRPV1RAB9ANPC1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110190344-A1 BENZIMIDAZOLE MODULATORS OF VR1 JANSSEN PHARMACEUTICA N.V. (BE) 2011-08-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190344-A1 BENZIMIDAZOLE MODULATORS OF VR1 VRK1, VRK2, VIL1 TRPV1 29/4885RAB9A 3985/4885NPC1 750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback